Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more common side effects people notice after moving to the 1.7mg Wegovy dose. Loose stools typically arrive in the first week or two after a dose increase, settle gradually for most people, and rarely require stopping treatment. That said, knowing what's expected, what isn't, and when to call for help makes a real difference to how you manage those early weeks. Wegovy (semaglutide) is a prescription-only medicine, and decisions about managing side effects at this dose always sit with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Moving from 1mg to 1.7mg is a meaningful jump in dose. Semaglutide works partly by slowing the rate at which food leaves your stomach and by acting on appetite-regulating receptors in the gut and brain. At each new dose level, those gut effects reassert themselves before your digestive system has had time to adapt. The result, for many people, is a short window of looser stools, urgency, or more frequent trips to the bathroom.
This isn't unique to 1.7mg. You may have noticed something similar when you moved from 0.5mg to 1mg. The pattern tends to be: a few days of disruption, gradual improvement, and then a new normal. The NHS semaglutide information page lists diarrhoea as a common side effect of the medicine across its titration schedule.
Eating smaller portions, avoiding high-fat or very rich meals, and giving yourself a little more time between eating and any activity that might aggravate things can all take the edge off. None of that replaces a conversation with your prescriber, but it's worth trying before concluding 1.7mg isn't right for you. Many people who struggle in week one are fine by week three. For more on the dose itself and how it fits the wider titration sequence, the Wegovy 1.7mg overview is a useful reference.
A question our prescribers hear most weeks is some version of: "It's been two weeks and I'm still not right, do I carry on?" The honest answer depends on a few things. Duration matters. Two to three weeks of mild-to-moderate loose stools after a dose increase is within the range of what the clinical evidence shows. Beyond three to four weeks without improvement, that's worth raising with your prescriber rather than assuming it will resolve.
Severity matters too. Mild means inconvenient. Moderate means it's affecting your day. Severe means you can't leave the house, you're losing significant fluid, or you're feeling dizzy and lightheaded. The last of those needs prompt clinical attention, not reassurance from an article.
If 1.7mg is genuinely not tolerable, staying at the previous dose for longer is a legitimate clinical option. The Wegovy dosing schedule is a guide, not a rigid countdown. Your prescriber can advise on timing. What you should not do is self-manage by skipping injections without telling anyone, that changes your clinical picture in ways that matter for your next review.
If you're curious how the 1.7mg to 2.4mg move compares in terms of side effect burden, the guide on stepping up to 2.4mg covers that transition specifically, and our page on diarrhoea at the 2.4mg dose goes into more detail about what to expect once you reach the maintenance level.
Most diarrhoea on semaglutide is uncomfortable but not dangerous. There are situations where it becomes something to act on quickly.
Dehydration is the most common risk. Repeated loose stools remove fluid faster than many people replace it. Thirst, a dry mouth, dark urine, or feeling light-headed when you stand are signs you need to drink more and potentially speak to someone. If you can't keep fluids down at all, that warrants same-day contact with a GP or pharmacy.
Severe abdominal pain is a different matter. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines including semaglutide. The warning sign is intense, persistent stomach pain (often reaching through to the back) that may or may not come with vomiting. This is not typical GI discomfort. If you experience it, stop eating and get medical help the same day. Don't wait for your next prescription review.
Signs of an allergic reaction (swelling, difficulty breathing, a spreading rash) are also a reason to seek emergency help immediately. Diarrhoea is listed among Wegovy's common side effects; serious hypersensitivity reactions are rare but documented. If something feels wrong in a way that goes beyond GI upset, trust that instinct and call 111 or 999 as the severity warrants. Unexpected or serious reactions can also be reported through the MHRA Yellow Card scheme, patient reports genuinely contribute to ongoing safety monitoring.
Staying hydrated is the single most useful thing you can do. Water is fine; oral rehydration sachets are better if you're losing a lot of fluid. Avoid caffeine and alcohol while symptoms are active, both irritate the gut and make fluid loss worse.
Smaller, lower-fat meals tend to produce fewer GI symptoms on semaglutide. You're probably already eating less due to appetite suppression, but the composition of what you eat matters too. Greasy or very rich food moves through a slowed GI tract in a way that can worsen loose stools specifically. Keeping a rough note of what you ate before a bad day can help you spot a pattern worth raising with your prescriber.
Some people find that taking their injection at night means the worst GI effects happen while they're asleep. That's anecdotal rather than clinical guidance, but it's a question worth putting to your prescriber. If you're also wondering where 1.7mg sits within the full treatment programme, our page on the average dose of Wegovy explains how most people progress through the titration schedule and what dose they typically end up at. For context on how this dose compares to the 1mg experience many people come from, the page on diarrhoea at the 1mg dose is worth reading alongside this one.
Ultimately, if you're unsure whether what you're experiencing is normal or needs attention, the right move is to speak with a clinician. Our prescribers cover exactly this kind of question as part of the review process. You can start a free consultation and get a same-day clinical review from a GPhC-registered prescriber who can assess your specific situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.